James Gilligan

James Patrick Gilligan was the founder of Unigene Laboratories, Inc. (founded in 1981) where he held the title of Vice President-Product Development.
He was also the founder of Herborium Group, Inc. (founded in 2002) where he held the titles of Co-President, Chief Operating Officer & Director.
Additionally, he was the founder of Tarsa Therapeutics, Inc. (founded in 2009) where he held the title of Chief Scientific Officer.
Dr. Gilligan is also the founder of The Bracken Group LLC.
Dr. Gilligan's current job is as the President & Chief Scientific Officer at Tryp Therapeutics, Inc. (since 2020).
His former jobs include being the Managing Partner at Solenture LLC (2018-2020) and the Principal at Taurus Development Group, Inc. (2018-2019).
In terms of education, Dr. Gilligan attended Bates College for his undergraduate degree, Seton Hall University for his graduate degree, and the University of Connecticut for his doctorate.